CGT Global

CGT Global was founded in 2010 with the mission to accelerate the cure and prevention of significant medical conditions. The company is dedicated to supporting cell and gene therapies, disease-specific treatments, medical research, clinical trials, and precision/regenerative medicine. As the nation's leading biospecimen provider, CGT Global offers human primary cells, stem cells, and disease-state products for various research organizations. The company is registered with the U.S. Food and Drug Administration (FDA) and operates four (4) brick-and-mortar locations across the United States, equipped with state-of-the-art cell manufacturing laboratories and CLIA certified/high-complexity diagnostics. With its focus on #celltherapy, #genetherapy, #primarycells, and other related areas, CGT Global plays a crucial role in advancing biomedical research and breakthrough treatments.